Overview

First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Phase I Single Ascending Dose (Part 1), phase IIa Proof Of Concept (Part 2)
Phase:
Phase 1
Details
Lead Sponsor:
Bioprojet
Treatments:
Diphenhydramine
Promethazine